Heart Failure News and Research

RSS
Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
STOP AF trial: Arctic Front Cardiac CryoAblation Catheter System reduces AF symptoms by 80%

STOP AF trial: Arctic Front Cardiac CryoAblation Catheter System reduces AF symptoms by 80%

Nile Therapeutics reports net loss of $1.9M for first-quarter 2010

Nile Therapeutics reports net loss of $1.9M for first-quarter 2010

FREEDOM trial results to be presented at Heart Rhythm 2010

FREEDOM trial results to be presented at Heart Rhythm 2010

GRNCM1 do not cause cardiac arrhythmias after transplantation: Preclinical study

GRNCM1 do not cause cardiac arrhythmias after transplantation: Preclinical study

GE Healthymagination Fund invests $5M in CardioDx

GE Healthymagination Fund invests $5M in CardioDx

Boston Scientific's ACUITY Break-Away Lead Delivery System receives FDA clearance

Boston Scientific's ACUITY Break-Away Lead Delivery System receives FDA clearance

ARCA biopharma regains compliance for continued listing on NASDAQ

ARCA biopharma regains compliance for continued listing on NASDAQ

St. Jude Medical to display new products, clinical solutions at Heart Rhythm 2010

St. Jude Medical to display new products, clinical solutions at Heart Rhythm 2010

FDA approves St. Jude Medical's Unify CRT-D and Fortify ICD devices

FDA approves St. Jude Medical's Unify CRT-D and Fortify ICD devices

Pfizer to acquire terguride from Ergonex Pharma GmbH for treatment of PAH

Pfizer to acquire terguride from Ergonex Pharma GmbH for treatment of PAH

Clinical Data expands PGxHealth's FAMILION tests to include two new tests to diagnose heart diseases

Clinical Data expands PGxHealth's FAMILION tests to include two new tests to diagnose heart diseases

St. Jude Medical launches Promote Quadra CRT-D in Europe

St. Jude Medical launches Promote Quadra CRT-D in Europe

CHD mortality rate in Ontario decreased by 35%: Study

CHD mortality rate in Ontario decreased by 35%: Study

Sanofi-aventis commences multinational Phase IIIb PALLAS trial of Multaq in permanent AF patients

Sanofi-aventis commences multinational Phase IIIb PALLAS trial of Multaq in permanent AF patients

FDA approves software upgrade to Boston Scientific's LATITUDE Patient Management system

FDA approves software upgrade to Boston Scientific's LATITUDE Patient Management system

Exposure to fine particulate matter can trigger cardiovascular deaths, heart attacks

Exposure to fine particulate matter can trigger cardiovascular deaths, heart attacks

Positive results from Cytori's Celution-based ADRC trial for treatment of no-option chronic heart disease patients

Positive results from Cytori's Celution-based ADRC trial for treatment of no-option chronic heart disease patients

Takeda enters co-promotion agreement with Janssen Pharma for VELCADE

Takeda enters co-promotion agreement with Janssen Pharma for VELCADE

Researchers study link between cognitive impairment and adherence problems among HF patients

Researchers study link between cognitive impairment and adherence problems among HF patients

Kent State University receives four-year, $2.7M grant to study cognitive status of heart failure patients

Kent State University receives four-year, $2.7M grant to study cognitive status of heart failure patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.